Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.
作者： R. Taylor Ripley , Valerie W. Rusch
DOI: 10.1016/J.THORSURG.2013.04.004
关键词: Medicine 、 Definitive chemoradiotherapy 、 Oncology 、 Stage (cooking) 、 Surgical resection 、 Induction therapy 、 Multimodality Therapy 、 Surgery 、 Lung cancer 、 Chemotherapy 、 Non small cell 、 Internal medicine
摘要: Patients with Stage III non-small cell lung cancer are best managed by multimodality therapy. N2 disease can be treated induction therapy (usually chemotherapy) followed surgical resection. whose medical comorbidities preclude surgery should definitive chemoradiotherapy. T3 or T4 tumors involving the superior sulcus spine chemoradiotherapy and
elsevier.com
sci-hub.se 参考文章(99)
Akira Masaoka, Yutaka Ito, Tsutomu Yasumitsu, Anterior approach for tumor of the superior sulcus. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 78, pp. 413- 415 ,(1979) , 10.1016/S0022-5223(19)38106-1
Donald L. Paulson, Carcinomas in the superior pulmonary sulcus. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 70, pp. 1095- 1104 ,(1975) , 10.1016/S0022-5223(19)39657-6
Lawrence H. Wyatt, Marshall N. Deltoff, Superior pulmonary sulcus tumor Journal of the Canadian Chiropractic Association. ,vol. 29, pp. 203- 204 ,(1985)
Shyam Varadarajulu, Mohamad Eloubeidi, Can endoscopic ultrasonography-guided fine-needle aspiration predict response to chemoradiation in non-small cell lung cancer? A pilot study. Respiration. ,vol. 73, pp. 213- 220 ,(2006) , 10.1159/000091533
David J. Sugarbaker, James Herndon, Leslie J. Kohman, Mark J. Krasna, Mark R. Green, Results of cancer and leukemia group B protocol 8935 ☆ ☆☆ ★ ★★ ♢ ♢♢ ♦: A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 109, pp. 473- 485 ,(1995) , 10.1016/S0022-5223(95)70278-4
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880
Nael Martini, Betty J. Flehinger, The role of surgery in N2 lung cancer. Surgical Clinics of North America. ,vol. 67, pp. 1037- 1049 ,(1987) , 10.1016/S0039-6109(16)44341-0
R L Burkes, R J Ginsberg, F A Shepherd, M E Blackstein, M E Goldberg, P F Waters, G A Patterson, T Todd, F G Pearson, J D Cooper, Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Journal of Clinical Oncology. ,vol. 10, pp. 580- 586 ,(1992) , 10.1200/JCO.1992.10.4.580
J. P. van Meerbeeck, G. W. P. M. Kramer, P. E. Y. Van Schil, C. Legrand, E. F. Smit, F. Schramel, V. C. Tjan-Heijnen, B. Biesma, C. Debruyne, N. van Zandwijk, T. A. W. Splinter, G. Giaccone, Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 99, pp. 442- 450 ,(2007) , 10.1093/JNCI/DJK093
Wei-An Song, Nai-Kang Zhou, Wei Wang, Xiang-Yang Chu, Chao-Yang Liang, Xiao-Dong Tian, Jun-Tang Guo, Xi Liu, Yang Liu, Wei-Min Dai, Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials Journal of Thoracic Oncology. ,vol. 5, pp. 510- 516 ,(2010) , 10.1097/JTO.0B013E3181CD3345